Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1962 1
1963 4
1964 2
1966 3
1967 1
1968 4
1969 4
1970 3
1971 5
1972 4
1973 9
1974 4
1975 24
1976 13
1977 12
1978 9
1979 7
1980 12
1981 11
1982 10
1983 20
1984 9
1985 24
1986 21
1987 15
1988 20
1989 30
1990 33
1991 25
1992 35
1993 55
1994 33
1995 59
1996 88
1997 99
1998 110
1999 155
2000 193
2001 215
2002 284
2003 281
2004 283
2005 374
2006 357
2007 373
2008 421
2009 451
2010 441
2011 503
2012 484
2013 483
2014 533
2015 594
2016 604
2017 619
2018 714
2019 732
2020 790
2021 844
2022 809
2023 879
2024 393

Text availability

Article attribute

Article type

Publication date

Search Results

12,263 results

Results by year

Filters applied: . Clear all
Page 1
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.
Dubinsky M, Bleakman AP, Panaccione R, Hibi T, Schreiber S, Rubin D, Dignass A, Redondo I, Gibble TH, Kayhan C, Travis S. Dubinsky M, et al. Am J Gastroenterol. 2023 Nov 1;118(11):1940-1953. doi: 10.14309/ajg.0000000000002404. Epub 2023 Jun 12. Am J Gastroenterol. 2023. PMID: 37436151 Free PMC article. Review.
Patients may not discuss BU often due to embarrassment, and healthcare providers may not address the symptom adequately due to the lack of awareness of validated tools and/or knowledge of the importance of assessing BU. ...Implications for the future management of U …
Patients may not discuss BU often due to embarrassment, and healthcare providers may not address the symptom adequately due to the la …
Primary Dentition Analysis: Exploring a Hidden Approach.
Nuvvula S, Vanjari K, Kamatham R, Gaddam KR. Nuvvula S, et al. Int J Clin Pediatr Dent. 2016 Jan-Mar;9(1):1-4. doi: 10.5005/jp-journals-10005-1323. Epub 2016 Apr 22. Int J Clin Pediatr Dent. 2016. PMID: 27274146 Free PMC article. Review.
AIM: To predict the canine and premolar dimensions, in the contemporary population, using BU approach and compare with the values obtained using Tanaka-Johnston (T/J) approach. ...The MDWs of the required teeth were measured on the models using electronic digital ve …
AIM: To predict the canine and premolar dimensions, in the contemporary population, using BU approach and compare with the values obt …
Revisiting Buruli ulcer.
Yotsu RR, Murase C, Sugawara M, Suzuki K, Nakanaga K, Ishii N, Asiedu K. Yotsu RR, et al. J Dermatol. 2015 Nov;42(11):1033-41. doi: 10.1111/1346-8138.13049. Epub 2015 Sep 1. J Dermatol. 2015. PMID: 26332541 Review.
Notably, there may be undiagnosed cases in other parts of the world where BU has not yet been reported. Japan exemplifies the finding that awareness among dermatologists plays a key role in BU case detection. ...This article will revisit BU, reviewing clinica …
Notably, there may be undiagnosed cases in other parts of the world where BU has not yet been reported. Japan exemplifies the finding …
Inherently Chiral Bambus[4]urils.
Mohite AR, Reany O. Mohite AR, et al. J Org Chem. 2020 Jul 17;85(14):9190-9200. doi: 10.1021/acs.joc.0c01174. Epub 2020 Jun 25. J Org Chem. 2020. PMID: 32521998
The relative "head-to-tail" arrangement of the N-substituents in Bn(4)Me(4)BU[4], 5a, clearly observed by X-ray spectroscopy analysis, determines the overall symmetry of the bambusuril structure. Chiral Pr(4)Me(4)BU[4], 4b, was resolved by chiral high-performance li …
The relative "head-to-tail" arrangement of the N-substituents in Bn(4)Me(4)BU[4], 5a, clearly observed by X-ray spectroscopy analysis …
The Buruli Ulcer.
Kumar S, Basu S, Bhartiya SK, Shukla VK. Kumar S, et al. Int J Low Extrem Wounds. 2015 Sep;14(3):217-23. doi: 10.1177/1534734615599653. Epub 2015 Aug 18. Int J Low Extrem Wounds. 2015. PMID: 26286931 Review.
Buruli ulcer (BU) is caused by Mycobacterium ulcerans and can manifest as a simple nodule or as aggressive skin ulcers leading to debilitating osteoarthritis or limb deformity. ...IS2404 polymerase chain reaction from ulcer swabs or biopsies is a rapid method for confirmat …
Buruli ulcer (BU) is caused by Mycobacterium ulcerans and can manifest as a simple nodule or as aggressive skin ulcers leading to deb …
POCUS, how can we include the brain? An overview.
Caldas J, Rynkowski CB, Robba C. Caldas J, et al. J Anesth Analg Crit Care. 2022 Dec 27;2(1):55. doi: 10.1186/s44158-022-00082-3. J Anesth Analg Crit Care. 2022. PMID: 37386605 Free PMC article. Review.
However, the brain has been overlooked in these protocols.Brain ultrasonography (BU) is easily available, and it allows a goal-directed approach thanks to its repeatability and immediate interpretation and provides a quick management and real time assessment of patients' c …
However, the brain has been overlooked in these protocols.Brain ultrasonography (BU) is easily available, and it allows a goal-direct …
Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.
Wang Q, Wu S, Ye X, Tan S, Huang F, Su G, Kijlstra A, Yang P. Wang Q, et al. J Autoimmun. 2023 May;137:103055. doi: 10.1016/j.jaut.2023.103055. Epub 2023 May 18. J Autoimmun. 2023. PMID: 37208257
A peptide antigen (SteTDR) encoded by BU specifically enriched Stenotrophomonas was identified to share homology with IRBP(161-180). ...Protein annotation identified 148 and 119 specific microbial proteins associated with BU and VKH, respectively. For metabolic func …
A peptide antigen (SteTDR) encoded by BU specifically enriched Stenotrophomonas was identified to share homology with IRBP(161-180). …
Challenges associated with the treatment of Buruli ulcer.
Aboagye SY, Kpeli G, Tuffour J, Yeboah-Manu D. Aboagye SY, et al. J Leukoc Biol. 2019 Feb;105(2):233-242. doi: 10.1002/JLB.MR0318-128. Epub 2018 Aug 31. J Leukoc Biol. 2019. PMID: 30168876 Review.
Despite these interventions, there are still challenges that bedevil the management of BU including paradoxical reactions, evolution of lesions after therapy, prolong viability of MU in BU lesions, and development of secondary bacterial infection. In this paper, we …
Despite these interventions, there are still challenges that bedevil the management of BU including paradoxical reactions, evolution …
A dual-functional buformin-mimicking poly(amido amine) for efficient and safe gene delivery.
Lu M, Xing H, Cheng L, Liu H, Lang L, Yang T, Zhao X, Xu H, Ding P. Lu M, et al. J Drug Target. 2020 Nov;28(9):923-932. doi: 10.1080/1061186X.2020.1729770. Epub 2020 Apr 21. J Drug Target. 2020. PMID: 32312081 Review.
CBA-Bu was equipped with high efficiency and safety profile for gene delivery, meanwhile exhibiting potential antitumor efficacy. ...Additionally, CBA-Bu had a lower IC50 value than its non-biguanide counterpart in two cancer cell lines. ...
CBA-Bu was equipped with high efficiency and safety profile for gene delivery, meanwhile exhibiting potential antitumor efficacy. ... …
The gut microbiota metabolite butyrate mitigates MPTP/MPP+ -induced Parkinson's disease by inhibiting the JAK2/STAT3 signaling pathway.
Ji LL, Huang TT, Mao LL, Xu YF, Chen WY, Wang WW, Wang LH. Ji LL, et al. Kaohsiung J Med Sci. 2023 Oct;39(10):1002-1010. doi: 10.1002/kjm2.12745. Kaohsiung J Med Sci. 2023. PMID: 37807941 Free article.
However, the specific molecular mechanism of BU has not been fully interpreted. This work aimed to verify the protective effects of BU against MPTP/MPP(+) -induced neurotoxicity and explore the mechanisms involved. ...BU treatment also attenuated MPP(+) -stim …
However, the specific molecular mechanism of BU has not been fully interpreted. This work aimed to verify the protective effects of …
12,263 results
You have reached the last available page of results. Please see the User Guide for more information.